Skip to main content
HIKMA Pharmaceuticals PLC logo

HIKMA Pharmaceuticals PLC — Investor Relations & Filings

Ticker · HIK ISIN · GB00B0LCW083 LEI · 549300BNS685UXH4JI75 IL Manufacturing
Open in API
Filings indexed 827 across all filing types
Latest filing 2025-11-06 Earnings Release
Country GB United Kingdom
Listing IL HIK

About HIKMA Pharmaceuticals PLC

https://www.hikma.com/home/

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.

Recent filings

Filing Released Lang Actions
November Trading Statement
Earnings Release Classification · 100% confidence The document is an official announcement from Hikma Pharmaceuticals PLC regarding their 2025 guidance and medium-term outlook. It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. While it contains financial performance highlights and outlook, it is an initial announcement of these figures rather than a full quarterly or annual report. It fits the definition of an Earnings Release (ER) as it provides key financial highlights, guidance updates, and management commentary on current trading performance. FY 2025
2025-11-06 English
Block listing Interim Review
Regulatory Filings Classification · 98% confidence The document is a 'Block Listing Six Monthly Return' filed by Hikma Pharmaceuticals PLC. This type of filing is a standard regulatory requirement for companies listed on the London Stock Exchange to report on the status of securities issued under specific incentive plans. Since it does not fit into the specific categories of financial reports, dividends, or M&A, and is a standard regulatory disclosure provided via the RNS (Regulatory News Service), it is classified as a Regulatory Filing.
2025-10-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by Persons Discharging Managerial Responsibilities (PDMRs) at Hikma Pharmaceuticals PLC. It explicitly follows the format required by Article 19 of the EU Market Abuse Regulation (MAR) for reporting insider dealings. The content details the acquisition of shares by specific executives (Riad Mishlawi, Susan Ringdal, etc.) via a dividend reinvestment plan. This aligns perfectly with the definition of a 'Director's Dealing' (DIRS) filing.
2025-09-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically Mazen Darwazah, an Executive Vice Chairman. It explicitly references Article 19 of the EU Market Abuse Regulation (MAR) regarding the disclosure of transactions by PDMRs. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing, which covers personal share transactions by company directors and executives.
2025-09-17 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director named Laura Balan. It explicitly references Article 19 of the EU Market Abuse Regulation (MAR) regarding the disclosure of transactions by persons discharging managerial responsibilities. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-08-22 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a Person Discharging Managerial Responsibility (PDMR), specifically detailing the exercise of share awards and the subsequent sale of shares to cover tax liabilities. This falls directly under the category of Director's Dealing (DIRS), which covers insider trades and transactions by company executives.
2025-08-13 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.